Cognition correlated more strongly with remembering in China (r=0.62) than Japan (r=0.42)
Semaglutide and tirzepatide are potent GLP-1 drugs that also trigger weight loss through appetite suppression and metabolic effects
Starting January 1, 2026, Medi-Cal stopped covering GLP-1 medications when they're prescribed specifically for weight loss in adults 21 and older
By leveraging this mechanism, GLP-1 medications make you feel fuller sooner and longer after eating, which can lead to reduced calorie intake and subsequent weight loss
Indoleamine 2, 3-dioxygenase, by degrading L-tryptophan, enhances carnitine palmitoyltransferase I activity and fatty acid oxidation, and exerts fatty acid-dependent effects in human alloreactive CD4+ T-cells
Users who obtained oral tirzepatide drops from high-quality compounding pharmacies with rigorous quality control may have genuinely different experiences than users who received products from less scrupulous sources